GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,732,000 | -63.9% | 49,997 | -69.5% | 0.23% | -68.1% |
| Q4 2021 | $4,803,000 | -45.1% | 164,082 | -18.8% | 0.72% | +85.2% |
| Q4 2020 | $8,754,000 | +7382.1% | 202,100 | +9523.8% | 0.39% | +4725.0% |
| Q3 2020 | $117,000 | -99.4% | 2,100 | -99.4% | 0.01% | -99.5% |
| Q2 2020 | $20,966,000 | +356.0% | 332,100 | +269.0% | 1.67% | +382.4% |
| Q1 2020 | $4,598,000 | -42.2% | 90,000 | -10.0% | 0.35% | -73.1% |
| Q4 2019 | $7,949,000 | – | 100,000 | – | 1.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |